Entry |
|
Name |
Amiodarone (USAN/INN) |
Formula |
C25H29I2NO3
|
Exact mass |
645.0237
|
Mol weight |
645.31
|
Structure |
|
Simcomp |
|
Class |
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01451 beta1-Adrenergic receptor agonist
DG01653 Antiarrhythmics
DG01648 Class III antiarrhythmic agent
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
|
Remark |
Product (DG00204): | D00636<JP/US> |
|
Efficacy |
Antiarrhythmic, Potassium channel blocker |
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
hsa04261 | Adrenergic signaling in cardiomyocytes |
hsa04270 | Vascular smooth muscle contraction |
|
Metabolism |
Enzyme: CYP3A4 [HSA: 1576]
|
Interaction |
|
Structure map |
map07232 | Potassium channel blocking and opening drugs |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01B ANTIARRHYTHMICS, CLASS I AND III
C01BD Antiarrhythmics, class III
C01BD01 Amiodarone
D02910 Amiodarone (USAN/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01451 beta1-Adrenergic receptor agonist
DG00204 Amiodarone
D02910 Amiodarone
DG01653 Antiarrhythmics
DG01648 Class III antiarrhythmic agent
DG00204 Amiodarone
D02910 Amiodarone
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00204 Amiodarone
D02910 Amiodarone
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA1
D02910 Amiodarone (USAN/INN)
ADRB1
D02910 Amiodarone (USAN/INN)
Ion channels
Voltage-gated ion channels
Sodium channels
SCN1A
D02910 Amiodarone (USAN/INN)
SCN2A
D02910 Amiodarone (USAN/INN)
SCN3A
D02910 Amiodarone (USAN/INN)
SCN4A
D02910 Amiodarone (USAN/INN)
SCN5A
D02910 Amiodarone (USAN/INN)
SCN8A
D02910 Amiodarone (USAN/INN)
SCN9A
D02910 Amiodarone (USAN/INN)
SCN10A
D02910 Amiodarone (USAN/INN)
SCN11A
D02910 Amiodarone (USAN/INN)
Potassium channels
KCND3
D02910 Amiodarone (USAN/INN)
KCNH2
D02910 Amiodarone (USAN/INN)
KCNQ1
D02910 Amiodarone (USAN/INN)
Inward rectifier channels (Kir)
KCNJ3
D02910 Amiodarone (USAN/INN)
KCNJ5
D02910 Amiodarone (USAN/INN)
KCNJ8
D02910 Amiodarone (USAN/INN)
KCNJ11
D02910 Amiodarone (USAN/INN)
KCNJ12
D02910 Amiodarone (USAN/INN)
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D02910
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01451 beta1-Adrenergic receptor agonist
DG00204 Amiodarone
DG01653 Antiarrhythmics
DG01648 Class III antiarrhythmic agent
DG00204 Amiodarone
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00204 Amiodarone
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 31
1 C8x C 17.7800 -21.6300
2 C8x C 17.7800 -23.0300
3 C8x C 18.9700 -23.7300
4 C8y C 20.2300 -23.0300
5 C8y C 20.2300 -21.6300
6 C8x C 18.9700 -20.8600
7 O2x O 21.5600 -23.4500
8 C8y C 22.4000 -22.3300
9 C8y C 21.5600 -21.1400
10 C5a C 21.5600 -19.7400
11 C8y C 22.7500 -19.0400
12 O5a O 20.3700 -19.0400
13 C8x C 24.0100 -19.7400
14 C8y C 25.2000 -19.0400
15 C8y C 25.2000 -17.6400
16 C8y C 24.0100 -16.9400
17 C8x C 22.7500 -17.6400
18 O2a O 26.4600 -16.9400
19 X I 26.4600 -19.7400
20 X I 24.0100 -15.5400
21 C1b C 27.6500 -17.6400
22 C1b C 28.8400 -16.9400
23 N1c N 30.0300 -17.6400
24 C1b C 31.2200 -16.9400
25 C1b C 30.0300 -19.0400
26 C1a C 31.2200 -19.7400
27 C1a C 32.4100 -17.6400
28 C1b C 23.7300 -22.3300
29 C1b C 24.4300 -23.5200
30 C1b C 25.8300 -23.5200
31 C1a C 26.5300 -24.7100
BOND 33
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 2
10 5 9 1
11 9 10 1
12 10 11 1
13 10 12 2
14 11 13 2
15 13 14 1
16 14 15 2
17 15 16 1
18 16 17 2
19 11 17 1
20 15 18 1
21 14 19 1
22 16 20 1
23 18 21 1
24 21 22 1
25 22 23 1
26 23 24 1
27 23 25 1
28 25 26 1
29 24 27 1
30 8 28 1
31 28 29 1
32 29 30 1
33 30 31 1
|